Who
Benjamin Meadows
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, Quanterix.
In numbers
- Trades disclosed
- 2
- Buys
- 1
- Sells
- 0
- Bought
- $19K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 May 2026
- Last trade
- 12 May 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 May – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 12 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Bought | $9,6953,500 at $2.77 | filing |
| 12 May 2026filed 12 Jun 2026 | QTRX QuanterixLife-science tools | SEC FORM 4 Bought | $9,6953,500 at $2.77 | filing |
News
Twist Bioscience (NASDAQ:TWST) versus Quanterix (NASDAQ:QTRX) Financial AnalysisQTRX · tickerreport.com · 15 Oct 2026
0 headlines in the last 90 days name Benjamin Meadows; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.